Dr. Minnie Sarwal
Minnie Sarwal is an MD with an MRCP, FRCP, DCh from London and a PhD in Molecular Genetics from Cambridge University, UK. She is Professor of Surgery at UCSF with prior appointments at Stanford University as Professor of Pediatrics, Immunology and Surgery and Medical Director of the Pediatric Kidney Transplant Program. She was a Founder/CSO of Organ-I, a Stanford University diagnostic company spin-out, sold to Immucor in 2014, which successfully commercialized the kSORT blood multigene assay for predicting kidney transplant rejection. She is also a Founder/CEO of 2 new UCSF spinouts. PPRA and KIT, which stand to improve diagnostics for kidney disease and is an inventor in over 20 patents. She heads an active translational research lab in organ transplantation at UCSF and serves on the Science Board of the FDA. She is a mentor for the UCSF/Berkeley Masters in Translational Medicine Program, serves on NIH study sections and is Chief Editor of a Nature journal; Frontiers in Nephrology. Minnie’s expertise spans new diagnostics and drug discovery/translation, regulatory and clinical trial design. She enjoys the rapid pace of startup environments, innovating, mentoring, teaching and directing patient care. She lives in Portola Valley with her husband and three children and enjoys tennis, piano, art and spending time with her miniature golden retriever.